ciprofloxacin has been researched along with lincomycin in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (10.53) | 18.2507 |
| 2000's | 6 (31.58) | 29.6817 |
| 2010's | 9 (47.37) | 24.3611 |
| 2020's | 2 (10.53) | 2.80 |
| Authors | Studies |
|---|---|
| Duewelhenke, N; Eysel, P; Krut, O | 1 |
| Cho, SH; Franzblau, SG; Hwang, CH; Pauli, GF; Wan, B; Warit, S | 1 |
| Al-Momani, W; Antunes, NT; Assunção, P; Ayling, RD; Mercier, P; Poveda, JB; Rosales, RS; Tavío, MM | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Avdeef, A; Tam, KY | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Guo, Y; Jia, G; Li, L; Wang, J; Wei, L; Xu, X; Yang, Y; Yu, Q; Zhou, Y | 1 |
| Auckenthaler, R; Peyret, M; Rohner, P | 1 |
| Gizatullina, ED; Guryleva, ME; Ozol, SM; Vizel', AA | 1 |
| Clerici, M; Luciani, F; Orlandi, C; Pomati, F; Zuccato, E | 1 |
| Aslam, M; Diarra, MS; Rempel, H; Service, C | 1 |
| Hu, L; Martin, HM; Strathmann, TJ | 1 |
| Hu, L; Stemig, AM; Strathmann, TJ; Wammer, KH | 1 |
| Hagenbuch, IM; Pinckney, JL | 1 |
| Fernandes, I; Guth, BE; Horton, DS; Magnoli, FC; Menezes, CA; Ozaki, CY; Piazza, RM; Rocha, LB; Silva, A; Vaz, TM | 1 |
| Odoi, A; Oguttu, JW; Qekwana, DN; Sithole, F | 1 |
| Gajda, A; Gbylik-Sikorska, M; Lisowski, A; Nowacka-Kozak, E; Posyniak, A; Łebkowska-Wieruszewska, B | 1 |
1 review(s) available for ciprofloxacin and lincomycin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
18 other study(ies) available for ciprofloxacin and lincomycin
| Article | Year |
|---|---|
Influence on mitochondria and cytotoxicity of different antibiotics administered in high concentrations on primary human osteoblasts and cell lines.
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Antimycin A; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cells, Cultured; Chloramphenicol; Clindamycin; Dose-Response Relationship, Drug; Fluoroquinolones; Glycolysis; HeLa Cells; Humans; Lactic Acid; Linezolid; Macrolides; Mitochondria; Osteoblasts; Oxazolidinones; Rotenone; Tetracyclines; Time Factors | 2007 |
Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Antitubercular Agents; DNA, Bacterial; Drug Evaluation, Preclinical; Mycobacterium tuberculosis; Oxygen | 2007 |
In vitro susceptibilities of Mycoplasma putrefaciens field isolates.
Topics: Anti-Bacterial Agents; France; Humans; Jordan; Lincomycin; Macrolides; Microbial Sensitivity Tests; Mycoplasma; Mycoplasma Infections; Tetracycline Resistance | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?
Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological; Permeability; Porosity; Regression Analysis | 2010 |
Metallo-β-lactamases inhibitor fisetin attenuates meropenem resistance in NDM-1-producing Escherichia coli.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Escherichia coli; Flavonols; Meropenem; Microbial Sensitivity Tests | 2022 |
Determination of MICs for staphylococci using the API ATB quinolone and API ATB macrolide systems.
Topics: Ciprofloxacin; Clindamycin; Dose-Response Relationship, Drug; Erythromycin; Humans; In Vitro Techniques; Lincomycin; Microbiological Techniques; Nalidixic Acid; Ofloxacin; Pefloxacin; Staphylococcus; Virginiamycin | 1993 |
[Antibiotic sensitivity of pathogenic microflora: data of the bacteriological laboratory at the antituberculosis clinic].
Topics: Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Antibiotics, Antitubercular; Bacteria; Carbenicillin; Cefuroxime; Cephalexin; Cephalosporins; Chloramphenicol; Ciprofloxacin; Doxycycline; Drug Therapy, Combination; Erythromycin; Female; Gentamicins; Humans; Inpatients; Lincomycin; Male; Microbial Sensitivity Tests; Neomycin; Outpatients; Oxacillin; Penicillins; Rifampin; Spiramycin; Streptomycin; Tetracycline | 1998 |
Effects and interactions in an environmentally relevant mixture of pharmaceuticals.
Topics: Atenolol; Bezafibrate; Cell Line; Cell Line, Tumor; Cell Proliferation; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Interactions; Escherichia coli; Humans; Lincomycin; Reproducibility of Results; Research Design; Risk Assessment; Toxicity Tests; Water Pollutants, Chemical | 2008 |
Characterization of antimicrobial resistance in Enterococcus spp. recovered from a commercial beef processing plant.
Topics: Animals; Cattle; Ciprofloxacin; Drug Resistance, Bacterial; Enterococcus; Erythromycin; Food Handling; Lincomycin; Meat; Microbial Sensitivity Tests; Random Amplified Polymorphic DNA Technique; Tetracycline Resistance; Virginiamycin | 2010 |
Oxidation kinetics of antibiotics during water treatment with potassium permanganate.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Hydrogen-Ion Concentration; Kinetics; Lincomycin; Manganese; Models, Chemical; Oxidation-Reduction; Potassium Permanganate; Temperature; Trimethoprim; Water; Water Purification; Water Supply | 2010 |
Oxidation of antibiotics during water treatment with potassium permanganate: reaction pathways and deactivation.
Topics: Anti-Bacterial Agents; Biological Assay; Ciprofloxacin; Escherichia coli; Lincomycin; Manganese; Oxidation-Reduction; Potassium Permanganate; Trimethoprim; Water Pollutants, Chemical; Water Purification; Water Supply | 2011 |
Toxic effect of the combined antibiotics ciprofloxacin, lincomycin, and tylosin on two species of marine diatoms.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Diatoms; Drug Synergism; Inhibitory Concentration 50; Lincomycin; Microscopy, Fluorescence; Models, Biological; Population Dynamics; Species Specificity; Tylosin | 2012 |
Different assay conditions for detecting the production and release of heat-labile and heat-stable toxins in enterotoxigenic Escherichia coli isolates.
Topics: Animals; Anti-Bacterial Agents; Bacterial Toxins; Bile Acids and Salts; Biological Assay; Ciprofloxacin; Enterotoxigenic Escherichia coli; Enterotoxins; Enzyme-Linked Immunosorbent Assay; Escherichia coli Proteins; Female; Immunoglobulin G; Lincomycin; Male; Mice, Inbred BALB C; Rabbits | 2013 |
Patterns and predictors of antimicrobial resistance among Staphylococcus spp. from canine clinical cases presented at a veterinary academic hospital in South Africa.
Topics: Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; Ciprofloxacin; Clindamycin; Dog Diseases; Dogs; Doxycycline; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Enrofloxacin; Female; Fluoroquinolones; Hospitals, Animal; Kanamycin; Lincomycin; Male; Retrospective Studies; South Africa; Spectinomycin; Staphylococcal Infections; Staphylococcus; Trimethoprim, Sulfamethoxazole Drug Combination; Tylosin | 2017 |
Transfer of enrofloxacin, ciprofloxacin, and lincomycin into eggshells and residue depletion in egg components after multiple oral administration to laying hens.
Topics: Administration, Oral; Animals; Chickens; Ciprofloxacin; Egg Shell; Egg Yolk; Eggs; Enrofloxacin; Female; Lincomycin; Ovum | 2021 |